Dublin, July 17, 2019 (GLOBE NEWSWIRE) -- The "Sirolimus Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global sirolimus market to grow with a sluggish CAGR over the forecast period from 2019-2025.
The report on the global sirolimus market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on sirolimus market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.
The report on sirolimus market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global sirolimus market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global sirolimus market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- Increased rate of kidney transplantation and occurrence of lifestyle-related diseases
- Improvement in health care infrastructure
2) Restraints
- Adverse effects observed with sirolimus
3) Opportunities
- Other therapeutic uses of sirolimus
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the sirolimus market.
2. Complete coverage of all the segments in the sirolimus market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global sirolimus market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Key Topics Covered
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Sirolimus Market Highlights
2.2. Sirolimus Market Projection
2.3. Sirolimus Market Regional Highlights
3. Global Sirolimus Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Application
3.4.2. Growth Matrix Analysis by Distribution Channel
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Sirolimus Market
4. Sirolimus Market Macro Indicator Analysis
5. Global Sirolimus Market by Application
5.1. Lymphangioleiomyomatosis (LAM)
5.2. Organ Transplant Rejection
5.3. Sirolimus Coated Balloons
5.4. Catheter Devices
6. Global Sirolimus Market by Distribution Channel
6.1. Hospital Pharmacies
6.2. Retail Pharmacies
6.3. Online Pharmacies
7. Global Sirolimus Market by Region
7.1. North America
7.2. Europe
7.3. Asia-Pacific
7.4. RoW
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Sirolimus Market
8.2. Companies Profiles
8.2.1. Intas Pharmaceuticals Ltd.
8.2.2. Cadila Healthcare Ltd.
8.2.3. Torrent Pharmaceuticals Ltd.
8.2.4. Stentys
8.2.5. Concept Medical Inc.
8.2.6. Biocon Limited
8.2.7. Pfizer Inc.
8.2.8. Other Companies
For more information about this report visit https://www.researchandmarkets.com/r/lkmoq8
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.